Welcome to the Eczema Studies Page

CURRENT STUDIES THAT MAY INTEREST YOU


A Study to Assess Nemolizumab in Participants with Moderate to Severe Atopic Dermatitis (Eczema)

Have you had atopic dermatitis (eczema) for at least 2 years? If so, you may be able to participate in a study to help determine how safe and effective a study drug, called nemolizumab, is in treating atopic dermatitis. Study participation may last up to 60 weeks and may involve up to 16 study visits. Compensation is provided.

Age Range
AGE:   18 and Up

Duration DURATION:  Up to 60 weeks
VISITS:  Up to 16
Location LOCATION:  Falk Medical Building - Oakland


MyPaTH Story Booth 2.0

Interested in sharing your story about health, illness, or research? Patients and caregivers are needed to participate in a research study to help learn more about topics that are important to you and that may improve health and health care. Participation involves one 45-minute session that takes place over the phone. Eligible participants must be able to read and understand English.

Age Range
AGE:   18 and Up

Duration DURATION:  45 minutes
VISITS:  1 visit or phone call
Location LOCATION:  By phone


ABT-494: Eczema Study

Have you been diagnosed with moderate to severe eczema? Are you ages 18-75? If so, you may be eligible to participate in a study to help researchers evaluate an investigational drug called upadacitinib, which is being tested as a treatment for several inflammatory diseases, including eczema. Compensation provided.

Age Range
AGE:   18 - 75

Duration VISITS:  multiple
Location LOCATION:  Falk Medical Building - Oakland


A Study to Evaluate Risankizumab in Participants with Moderate to Severe Atopic Dermatitis

Have you been diagnosed with moderate-to-severe atopic dermatitis (eczema) for at least the past 2 years? If so, you may be eligible to participate in a study of an investigational drug called risankizumab in subjects with atopic dermatitis. Involves 11 visits over up to 65 weeks. Compensation is provided.

Age Range
AGE:   18 and Up

Duration DURATION:  Up to 65 weeks
VISITS:  11 visits & 1 phone call
Location LOCATION:  Falk Medical Building - Oakland


DRM-18-016: Eczema Study

Have you been diagnosed with eczema that is not responding to treatment? If so, you may be eligible to participate in a study to help researchers find out if an investigational drug called tradipitant is safe and effective at treating eczema. Eligible participants are 18-70 years old and have chronic itchy skin despite the use of steroids and antihistamines. Compensation provided.

Age Range
AGE:   18 - 70

Duration VISITS:  6 visits
Location LOCATION:  Falk Medical Building - Oakland


All of Us Pennsylvania Research Program

You may be able to change the future of medicine. The All of Us PA Research Program is enrolling adults 18 years of age or older. This may be your chance to improve how your children and your children’s children receive medical care.

Age Range
AGE:   18 and Up

Duration VISITS:  one initial visit
Location LOCATION:  Convenient locations near you including Altoona, Monroeville, North Hills, Oakland, Philadelphia, Shadyside, the South Hills and more!



RELATED RESEARCH AREAS:
  Skin, Hair, and Nails

Pitt+Me

 
OUR PRIVACY POLICY
 

Remember, your personal information is kept confidential, and participation in research is always voluntary.

 
Friend UsFriend Us     Tweet UsTweet Us     YouTubeYouTube    
 
CTSI.PITT.EDU

This website is maintained by the Clinical and Translational Science Institute.
© Copyright 2018, University of Pittsburgh. All rights reserved.

PITT.EDU